Cargando…
Exploring targeted therapy of osteosarcoma using proteomics data
Despite multimodal therapeutic treatments of osteosarcoma (OS), some patients develop resistance to currently available regimens and eventually end up with recurrent or metastatic outcomes. Many attempts have been made to discover effective drugs for improving outcome; however, due to the heterogene...
Autores principales: | Chaiyawat, Parunya, Settakorn, Jongkolnee, Sangsin, Apiruk, Teeyakasem, Pimpisa, Klangjorhor, Jeerawan, Soongkhaw, Aungsumalee, Pruksakorn, Dumnoensun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295800/ https://www.ncbi.nlm.nih.gov/pubmed/28203090 http://dx.doi.org/10.2147/OTT.S119993 |
Ejemplares similares
-
Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications
por: Chaiyawat, Parunya, et al.
Publicado: (2018) -
Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2019) -
Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2017) -
Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2020) -
IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2021)